Human medicines European public assessment report (EPAR): Dafiro, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Dafiro, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Copalia, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Copalia, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Exforge, amlodipine,valsartan, Date of authorisation: 16/01/2007, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Exforge, amlodipine,valsartan, Date of authorisation: 16/01/2007, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Descovy, emtricitabine,tenofovir alafenamide, Date of authorisation: 21/04/2016, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Descovy, emtricitabine,tenofovir alafenamide, Date of authorisation: 21/04/2016, Revision: 21, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness